📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase. (2010)

First Author: Pavlu J

Attributed to: Expansion of the GMP facility for Stem Cell Therapy at Imperial College funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2010-01-263624

PubMed Identifier: 20304808

Publication URI: http://europepmc.org/abstract/MED/20304808

Type: Journal Article/Review

Volume: 115

Parent Publication: Blood

Issue: 20

ISSN: 0006-4971